Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials

Authors
Shepherd, FA Fossella, FV Lynch, T Armand, JP Rigas, JR Kris, MG
Citation
Fa. Shepherd et al., Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials, SEMIN ONCOL, 28(1), 2001, pp. 4-9
Citations number
19
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
28
Issue
1
Year of publication
2001
Supplement
2
Pages
4 - 9
Database
ISI
SICI code
0093-7754(200102)28:1<4:D(SSAQ>2.0.ZU;2-J